Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000
Novo Nordisk A/S Class B shares ended Friday at 369.6 Danish crowns, slipping 0.8 crown. Investors brace for a results-packed week, keen on fresh demand figures for the company’s new weight-loss drug.